Immune checkpoint inhibitors have revolutionized treatment of non-small cell lung cancer. In this study, breath prophiles were collected from 143 patients and a single biomarker profile was created that detected responses to anti-PD-1 treatment with 89% accuracy.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Lung - Cancer
September 20, 2019
August 22, 2019
This study of over 25,000 pts from the International Lung Cancer Consortium identified underweight and severly obese patients as having poorer survival than others, whereas a survival advantage was evident among patients who were overweight or mildly obese. Decreased BMI (wt loss) was associated with poorer outcomes across all BMI categories.
August 20, 2019
Interesting follow-up study of 208 pulmonary ground -glass opacities in 160 subjects, with a yield of three adenocardinomas.
August 15, 2019
Regionalization of care for complex problems remains an open question in most countries. This review demonstrated that, for high risk cancer operations in the US, the Leapfrog group's volume standards did not differentiate between surgical mortality outcomes for lung and esophageal cancer surgery.
August 8, 2019
A detailed and robust meta-analysis asserting lack of strong evidence supporting either modality.
August 1, 2019
Filmed at the 2019 STS Annual Meeting in San Diego, California, Mara Antonoff of the MD Anderson Cancer Center moderates a discussion on how immunotherapy is changing the landscape of surgical lung cancer care.
July 22, 2019
This video demonstrates a robotic right lower and middle bilobectomy.
July 19, 2019
Patient Care and General Interest
July 15, 2019
This video demonstrates a right upper lobectomy enhanced by thoracic LigaSure and Medtronic Signia.
July 10, 2019
Spread through air space (STAS) is a pattern of lung adenocarcinoma invasion, and it is a predictor of recurrence in patients with early-stage lung adenocarcinoma. However, less is known about the role of STAS in advanced lung adenocarcinoma.